Chapter 35
Integrative Oncology: Alternative and Complementary Treatments
Barrie R. Cassileth MS, PhD,
Jyothirmai Gubili MS, FACS,
Barrie R. Cassileth MS, PhD
Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Search for more papers by this authorJyothirmai Gubili MS, FACS
Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Search for more papers by this authorBarrie R. Cassileth MS, PhD,
Jyothirmai Gubili MS, FACS,
Barrie R. Cassileth MS, PhD
Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Search for more papers by this authorJyothirmai Gubili MS, FACS
Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Search for more papers by this authorBook Editor(s):Pierre-Alain Clavien MD, Phd, FACS, FRCS,
Stefan Breitenstein MD,
Pierre-Alain Clavien MD, Phd, FACS, FRCS
Professor Chairman
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorStefan Breitenstein MD
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorFirst published: 09 December 2009
Summary
This chapter contains sections titled:
-
Introduction
-
Complementary and alternative medicine today
-
Alternative medical systems
-
Complementary therapies
-
Conclusion
-
References
-
Self-assessment questions
-
Self-assessment answers
References
-
Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83: 777–82.
10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- Shen J, Andersen R, Albert PS, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2002; 2: 8.
- Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 2006; 12: 467–74.
- Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007; 7: 4.
- Green S. “Antineoplastons”. An unproved cancer therapy. JAMA 1992; 267: 2924–8.
- Miller DR, Anderson GT, Stark JJ, Granick JL, Richardson D. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998; 16: 3649–55.
- Loprinzi CL, Levitt R, Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer 2005; 104: 176–82.
- AboutHerbs Web site. http://www.mskcc.org/aboutherbs. (accessed November 27 2007).
- Questionable methods of cancer management: ‘nutritional’ therapies. CA Cancer J Clin 1993; 43: 309–19.
- Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA 1992; 268: 3224–7.
- Detoxification at http://www.holisticmed.com/detox. http:// www.holisticmed.com/detox/ (accessed November 27 2007.
- D& Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005; 55: 319–21.
- Etheridge AS, Black SR, Patel PR, So J, Mathews JM. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med 2007; 73: 731–41.
- Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M, Ogawa N. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterol Jpn 1989; 24: 715–9.
- Yano H, Mizoguchi A, Fukuda K, et al. The herbal medicine shosaiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 1994; 54: 448–54.
- Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fi brosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-defi cient L-amino acid-defi ned diet. J Hepatol 1998; 28: 298–306.
- Yamashiki M, Nishimura A, Suzuki H, Sakaguchi S, Kosaka Y. Effects of the Japanese herbal medicine “Sho-saiko-to” (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 1997; 25: 1390–7.
-
Oka H, Yamamoto S, Kuroki T, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995; 76: 743–9.
10.1002/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- Pomeranz B, Chiu D. Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci 1976; 19: 1757–62.
- Peets JM, Pomeranz B. CXBK mice defi cient in opiate receptors show poor electroacupuncture analgesia. Nature 1978; 273: 675–6.
- Clement-Jones V, McLoughlin L, Tomlin S, Besser GM, Rees LH, Wen HL. Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 1980; 2: 946–9.
- Guo HF, Tian J, Wang X, Fang Y, Hou Y, Han J. Brain substrates activated by electroacupuncture of different frequencies (I): Comparative study on the expression of oncogene c-fos and genes coding for three opioid peptides. Brain Res Mol Brain Res 1996; 43: 157–66.
- Guo HF, Tian J, Wang X, Fang Y, Hou Y, Han J. Brain substrates activated by electroacupuncture (EA) of different frequencies (II): Role of Fos/Jun proteins in EA-induced transcription of preproenkephalin and preprodynorphin genes. Brain Res Mol Brain Res 1996; 43: 167–73.
- Manheimer E, White A, Berman B, Forys K, Ernst E. Metaanalysis: acupuncture for low back pain. Ann Intern Med 2005; 142: 651–63.
- Melchart D, Linde K, Fischer P, et al. Acupuncture for idiopathic headache. Cochrane Database Syst Rev 2001 (1): CD001218.
- Ezzo J, Streitberger K, Schneider A. Cochrane systematic reviews examine P6 acupuncture-point stimulation for nausea and vomiting. J Altern Complement Med 2006; 12: 489–95.
- Belgrade MJ, Solomon LM, Lichter EA. Effect of acupuncture on experimentally induced itch. Acta Derm Venereol 1984; 64: 129–33.
- Duo LJ. Electrical needle therapy of uremic pruritus. Nephron 1987; 47: 179–83.
- Orwin JM, Fozard JR. Blockade of the flare response to intradermal 5-hydroxytryptamine in man by MDL 72.222, a selective antagonist at neuronal 5-hydroxytryptamine receptors. Eur J Clin Pharmacol 1986; 30: 209–12.
- Richardson BP, Engel G, Donatsch P, Stadler PA. Identifi cation of serotonin M-receptor subtypes and their specifi c blockade by a new class of drugs. Nature 1985; 316: 126–31.
- Eschalier A, Kayser V, Guilbaud G. Influence of a specifi c 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats. Pain 1989; 36: 249–55.
- Sprott H, Franke S, Kluge H, Hein G. Pain treatment of fi bromyalgia by acupuncture. Rheumatol Int 1998; 18: 35–6.
- White JM. Effects of relaxing music on cardiac autonomic balance and anxiety after acute myocardial infarction. Am J Crit Care 1999; 8: 220–30.
- Chlan L. Effectiveness of a music therapy intervention on relaxation and anxiety for patients receiving ventilatory assistance. Heart Lung 1998; 27: 169–76.
- Beck SL. The therapeutic use of music for cancer-related pain. Oncol Nurs Forum 1991; 18: 1327–37.
- Good M, Stanton-Hicks M, Grass JA, et al. Relaxation and music to reduce postsurgical pain. J Adv Nurs 2001; 33: 208–15.
- Cassileth BR, Vickers AJ, Magill CA. Music therapy for mood disturbance during hospitalization for autologous stem cell transplantation: a randomized controlled trial. Cancer 2003; 98: 2723–9.
- Grealish L, Lomasney A, Whiteman B. Foot massage. A nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs 2000; 23: 237–43.
- Post-White J, Kinney ME, Savik K, Gau JB, Wilcox C, Lerner I. Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther 2003; 2: 332–44.
- Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004; 18: 87–92.
- Stephenson NL, Weinrich SP, Tavakoli AS. The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum 2000; 27: 67–72.
- Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 2004; 28: 244–9.
- Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004; 100: 2253–60.
- Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003; 65: 571–81.
- Zeltzer LK, Dolgin MJ, LeBaron S, LeBaron C. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics 1991; 88: 34–42.
- Walker LG, Walker MB, Ogston K, et al. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer 1999; 80: 262–8.
- Gaston-Johansson F, Fall-Dickson JM, Nanda J, et al. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs 2000; 23: 277–85.
